Global Cancer Tumor Profiling Market Size, Status and Forecast 2019-2025

payment-methods.png
Secure Payment Methods

Global Cancer Tumor Profiling market is anticipated to grow at a CAGR of XX% by 2023, according to a new report published by Marketintelligencedata Inc. The report segments the market and forecasts its size, by volume and value, on the basis of application, by products, and by geography (North America, Europe, Asia-Pacific, MEA and South America).

The Global Market for Cancer Tumor Profiling to 2023 offers detailed coverage of guanidine Cancer Tumor Profiling industry and presents main market trends. The market research gives historical and forecast market size, demand and production forecasts, end-use demand details, price trends, and company shares of the leading Cancer Tumor Profiling producers to provide exhaustive coverage of the guanidine carbonate.

This research report includes following contents:

  • Cancer Tumor Profiling Product details, including pictures and technical specifications
  • Cancer Tumor Profiling manufacturers, distributors and channels
  • Major players present in the Cancer Tumor Profiling
  • Information on competitor market shares, revenue, unit sales etc
  • Breakdown by applications for the Market
  • Value chain and distributor details in the market

Key vendors:

  • Qiagen N.V.
  • Roche Molecular Systems Inc.
  • Abott Molecular
  • Illumina Inc.
  • NeoGenomics Laboratories
  • HTG Molecular Diagnostic
  • Genomic Health Inc.
  • Hologic Gen-Probe
  • BD Biosciences
  • Siemens Healthineers
  • Claris Life Sciences
  • Personal Genome Diagnostics, Inc.
  • Perthera, Inc.
  • Foundation Medicine, Inc
  • V., Strand
  • ApoCell
  • Contextual Genomics
  • Agendia
  • GenScript

Key regions:

United States, Europe, China, Japan, Southeast Asia, India, Central & South America

Additionally, the market is segmented by the following sectors

  • Next-generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry (IHC)
  • In Situ Hybridization (ISH)
  • Microarray
  • Others

Not only this, figures covering the end user applications are also provided according to the following classification

  • Personalized Medicine
  • Diagnostics
  • Biomarker Discovery
  • Prognostics
  • Research Applications

In summary, the report serves to study and analyse the Cancer Tumor Profiling size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cancer Tumor Profiling, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

Overall the report is an excellent source for managers, researches and top executives alike to analyse and get clarity on the market standings and business forecast. We provide the information after thorough research and analysis saving precious hours and budget for the companies. We have been serving major clients like Sony, BCG, PWC, Mck, Hewlett Packard, Technicolor Etc.

  • 1 Report Overview
    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Cancer Tumor Profiling Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Next-generation Sequencing (NGS)
      • 1.4.3 Polymerase Chain Reaction (PCR)
      • 1.4.4 Immunohistochemistry (IHC)
      • 1.4.5 In Situ Hybridization (ISH)
      • 1.4.6 Microarray
      • 1.4.7 Others
    • 1.5 Market by Application
      • 1.5.1 Global Cancer Tumor Profiling Market Share by Application (2014-2025)
      • 1.5.2 Personalized Medicine
      • 1.5.3 Diagnostics
      • 1.5.4 Biomarker Discovery
      • 1.5.5 Prognostics
      • 1.5.6 Research Applications
    • 1.6 Study Objectives
    • 1.7 Years Considered
  • 2 Global Growth Trends
    • 2.1 Cancer Tumor Profiling Market Size
    • 2.2 Cancer Tumor Profiling Growth Trends by Regions
      • 2.2.1 Cancer Tumor Profiling Market Size by Regions (2014-2025)
      • 2.2.2 Cancer Tumor Profiling Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities
  • 3 Market Share by Key Players
    • 3.1 Cancer Tumor Profiling Market Size by Manufacturers
      • 3.1.1 Global Cancer Tumor Profiling Revenue by Manufacturers (2014-2018)
      • 3.1.2 Global Cancer Tumor Profiling Revenue Market Share by Manufacturers (2014-2018)
      • 3.1.3 Global Cancer Tumor Profiling Market Concentration Ratio (CR5 and HHI)
    • 3.2 Cancer Tumor Profiling Key Players Head office and Area Served
    • 3.3 Key Players Cancer Tumor Profiling Product/Solution/Service
    • 3.4 Date of Enter into Cancer Tumor Profiling Market
    • 3.5 Mergers & Acquisitions, Expansion Plans
  • 4 Breakdown Data by Type and Application
    • 4.1 Global Cancer Tumor Profiling Market Size by Type (2014-2019)
    • 4.2 Global Cancer Tumor Profiling Market Size by Application (2014-2019)
  • 5 United States
    • 5.1 United States Cancer Tumor Profiling Market Size (2014-2019)
    • 5.2 Cancer Tumor Profiling Key Players in United States
    • 5.3 United States Cancer Tumor Profiling Market Size by Type
    • 5.4 United States Cancer Tumor Profiling Market Size by Application
  • 6 Europe
    • 6.1 Europe Cancer Tumor Profiling Market Size (2014-2019)
    • 6.2 Cancer Tumor Profiling Key Players in Europe
    • 6.3 Europe Cancer Tumor Profiling Market Size by Type
    • 6.4 Europe Cancer Tumor Profiling Market Size by Application
  • 7 China
    • 7.1 China Cancer Tumor Profiling Market Size (2014-2019)
    • 7.2 Cancer Tumor Profiling Key Players in China
    • 7.3 China Cancer Tumor Profiling Market Size by Type
    • 7.4 China Cancer Tumor Profiling Market Size by Application
  • 8 Japan
    • 8.1 Japan Cancer Tumor Profiling Market Size (2014-2019)
    • 8.2 Cancer Tumor Profiling Key Players in Japan
    • 8.3 Japan Cancer Tumor Profiling Market Size by Type
    • 8.4 Japan Cancer Tumor Profiling Market Size by Application
  • 9 Southeast Asia
    • 9.1 Southeast Asia Cancer Tumor Profiling Market Size (2014-2019)
    • 9.2 Cancer Tumor Profiling Key Players in Southeast Asia
    • 9.3 Southeast Asia Cancer Tumor Profiling Market Size by Type
    • 9.4 Southeast Asia Cancer Tumor Profiling Market Size by Application
  • 10 India
    • 10.1 India Cancer Tumor Profiling Market Size (2014-2019)
    • 10.2 Cancer Tumor Profiling Key Players in India
    • 10.3 India Cancer Tumor Profiling Market Size by Type
    • 10.4 India Cancer Tumor Profiling Market Size by Application
  • 11 Central & South America
    • 11.1 Central & South America Cancer Tumor Profiling Market Size (2014-2019)
    • 11.2 Cancer Tumor Profiling Key Players in Central & South America
    • 11.3 Central & South America Cancer Tumor Profiling Market Size by Type
    • 11.4 Central & South America Cancer Tumor Profiling Market Size by Application
  • 12 International Players Profiles
    • 12.1 Qiagen N.V.
      • 12.1.1 Qiagen N.V. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Cancer Tumor Profiling Introduction
      • 12.1.4 Qiagen N.V. Revenue in Cancer Tumor Profiling Business (2014-2019)
      • 12.1.5 Qiagen N.V. Recent Development
    • 12.2 Roche Molecular Systems Inc.
      • 12.2.1 Roche Molecular Systems Inc. Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Cancer Tumor Profiling Introduction
      • 12.2.4 Roche Molecular Systems Inc. Revenue in Cancer Tumor Profiling Business (2014-2019)
      • 12.2.5 Roche Molecular Systems Inc. Recent Development
    • 12.3 Abott Molecular
      • 12.3.1 Abott Molecular Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Cancer Tumor Profiling Introduction
      • 12.3.4 Abott Molecular Revenue in Cancer Tumor Profiling Business (2014-2019)
      • 12.3.5 Abott Molecular Recent Development
    • 12.4 Illumina Inc.
      • 12.4.1 Illumina Inc. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Cancer Tumor Profiling Introduction
      • 12.4.4 Illumina Inc. Revenue in Cancer Tumor Profiling Business (2014-2019)
      • 12.4.5 Illumina Inc. Recent Development
    • 12.5 NeoGenomics Laboratories
      • 12.5.1 NeoGenomics Laboratories Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Cancer Tumor Profiling Introduction
      • 12.5.4 NeoGenomics Laboratories Revenue in Cancer Tumor Profiling Business (2014-2019)
      • 12.5.5 NeoGenomics Laboratories Recent Development
    • 12.6 HTG Molecular Diagnostic
      • 12.6.1 HTG Molecular Diagnostic Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Cancer Tumor Profiling Introduction
      • 12.6.4 HTG Molecular Diagnostic Revenue in Cancer Tumor Profiling Business (2014-2019)
      • 12.6.5 HTG Molecular Diagnostic Recent Development
    • 12.7 Genomic Health Inc.
      • 12.7.1 Genomic Health Inc. Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Cancer Tumor Profiling Introduction
      • 12.7.4 Genomic Health Inc. Revenue in Cancer Tumor Profiling Business (2014-2019)
      • 12.7.5 Genomic Health Inc. Recent Development
    • 12.8 Hologic Gen-Probe
      • 12.8.1 Hologic Gen-Probe Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Cancer Tumor Profiling Introduction
      • 12.8.4 Hologic Gen-Probe Revenue in Cancer Tumor Profiling Business (2014-2019)
      • 12.8.5 Hologic Gen-Probe Recent Development
    • 12.9 BD Biosciences
      • 12.9.1 BD Biosciences Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Cancer Tumor Profiling Introduction
      • 12.9.4 BD Biosciences Revenue in Cancer Tumor Profiling Business (2014-2019)
      • 12.9.5 BD Biosciences Recent Development
    • 12.10 Siemens Healthineers
      • 12.10.1 Siemens Healthineers Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Cancer Tumor Profiling Introduction
      • 12.10.4 Siemens Healthineers Revenue in Cancer Tumor Profiling Business (2014-2019)
      • 12.10.5 Siemens Healthineers Recent Development
    • 12.11 Claris Life Sciences
    • 12.12 Personal Genome Diagnostics, Inc.
    • 12.13 Perthera, Inc.
    • 12.14 Foundation Medicine, Inc
    • 12.15 V., Strand
    • 12.16 ApoCell
    • 12.17 Contextual Genomics
    • 12.18 Agendia
    • 12.19 GenScript
  • 13 Market Forecast 2019-2025
    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)
  • 14 Analyst’s Viewpoints/Conclusions
  • 15 Appendix
    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
        • 15.1.1.1 Research Programs/Design
        • 15.1.1.2 Market Size Estimation
        • 12.1.1.3 Market Breakdown and Data Triangulation
      • 15.1.2 Data Source
        • 15.1.2.1 Secondary Sources
        • 15.1.2.2 Primary Sources
    • 15.2 Disclaimer
    • 15.3 Author Details

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Our Happy Customers